Antioxidative Effect of Ridl. Extract for Protecting against Vascular Dementia.

Pratchaya Kaewkaen
Author Information
  1. Pratchaya Kaewkaen: College of Research Methodology and Cognitive Science, Burapha University, Mueang, Chonburi 20131, Thailand. ORCID

Abstract

Vascular dementia is caused by decreased blood flow to the brain, which leads to neuronal damage and subsequent death. Therefore, development of alternative neuroprotective agents is critical. This study is aimed at investigating the effects of Ridl. extract or Siam cardamom extract (SCE) on oxidative markers in a rat model of vascular dementia. The phenolic content of SCE, represented as gallic acid equivalent (mg/100 GAE), was discovered to be 128.56 ± 0.58 mg/100 GAE. The EC50 values for the 2,2-diphenyl-1-picrylhydrazyl radical scavenging activities of SCE were 32.48 ± 0.39 g/mL. In addition, the reducing power of SCE, via a ferric reducing antioxidant power assay, was also determined, with an EC50 value of 142.55 ± 0.56 g/mL. SCE was administered orally to adult male Wistar rats weighing 250-300 g at doses of 100, 300, and 500 mg/kg over the course of 14 days; then, the rats underwent surgery of the right middle cerebral artery, producing an occlusion imitating vascular dementia in a controlled environment. All rats were euthanized to obtain brain tissue for biochemical testing and analysis. The results showed that malondialdehyde decreased and superoxide dismutase, catalase, and glutathione peroxidase increased at all doses (100, 300, and 500 mg/kg) of SCE ( < 0.05). In addition, SCE was shown to lower the expression level of S100B, a marker of neurologic injury ( < 0.05). The free radical scavenging and anti-inflammatory capabilities of SCE suggest that it has the potential to be used as a food supplement to protect against oxidative damage in vascular dementia. However, further clinical investigations are essential to elucidate this in clinical trials.

References

  1. Int J Food Sci. 2021 Jan 14;2021:8871301 [PMID: 33511200]
  2. Anal Biochem. 1996 Jul 15;239(1):70-6 [PMID: 8660627]
  3. Eur J Biochem. 1974 Oct 1;48(1):137-45 [PMID: 4141308]
  4. J Clin Psychiatry. 2007 Jul;68(7):1031-7 [PMID: 17685739]
  5. Mar Drugs. 2019 Nov 04;17(11): [PMID: 31690015]
  6. Int J Mol Sci. 2021 May 24;22(11): [PMID: 34073816]
  7. Methods Enzymol. 1981;77:325-33 [PMID: 7329310]
  8. Int J Food Sci. 2020 May 7;2020:9081686 [PMID: 32455130]
  9. Aging Dis. 2016 May 27;7(3):295-306 [PMID: 27330844]
  10. Anaerobe. 2020 Feb;61:102089 [PMID: 31430531]
  11. BMC Complement Altern Med. 2017 Mar 3;17(1):135 [PMID: 28253877]
  12. Pharmacopsychiatry. 1999 Mar;32 Suppl 1:2-9 [PMID: 10338102]
  13. Curr Med Chem. 2015;22(10):1258-77 [PMID: 25666795]
  14. Brain Res. 2015 Oct 22;1624:536-544 [PMID: 26254728]
  15. Sleep Med. 2006 Aug;7(5):431-5 [PMID: 16750933]
  16. Stroke. 1989 Jan;20(1):84-91 [PMID: 2643202]
  17. Oxid Med Cell Longev. 2016;2016:3164734 [PMID: 26881021]
  18. Bio Protoc. 2019 Jun 20;9(12):e3263 [PMID: 33654783]
  19. Front Aging Neurosci. 2010 Mar 30;2:12 [PMID: 20552050]
  20. J Alzheimers Dis. 2019;72(4):1119-1127 [PMID: 31683478]
  21. Front Neurol. 2022 Mar 03;13:765969 [PMID: 35309553]
  22. Medicine (Baltimore). 2022 Aug 5;101(31):e29307 [PMID: 35945739]
  23. Biochem J. 1986 Jul 1;237(1):175-80 [PMID: 3026308]
  24. Int J Mol Sci. 2015 Nov 17;16(11):27457-69 [PMID: 26593900]
  25. Clin Exp Hypertens. 2020 Oct 2;42(7):581-589 [PMID: 32202168]
  26. Shock. 2004 Aug;22(2):102-7 [PMID: 15257081]
  27. Front Neurol. 2021 Mar 18;12:664445 [PMID: 33815264]

Word Cloud

Created with Highcharts 10.0.0SCE0dementiavascular±ratsVasculardecreasedbraindamageRidlextractoxidativeGAEEC50radicalscavengingadditionreducingpowerdoses100300500 mg/kg<05clinicalcausedbloodflowleadsneuronalsubsequentdeathThereforedevelopmentalternativeneuroprotectiveagentscriticalstudyaimedinvestigatingeffectsSiamcardamommarkersratmodelphenoliccontentrepresentedgallicacidequivalentmg/100discovered1285658 mg/100values22-diphenyl-1-picrylhydrazylactivities324839 g/mLviaferricantioxidantassayalsodeterminedvalue1425556 g/mLadministeredorallyadultmaleWistarweighing250-300 gcourse14daysunderwentsurgeryrightmiddlecerebralarteryproducingocclusionimitatingcontrolledenvironmenteuthanizedobtaintissuebiochemicaltestinganalysisresultsshowedmalondialdehydesuperoxidedismutasecatalaseglutathioneperoxidaseincreasedshownlowerexpressionlevelS100Bmarkerneurologicinjuryfreeanti-inflammatorycapabilitiessuggestpotentialusedfoodsupplementprotectHoweverinvestigationsessentialelucidatetrialsAntioxidativeEffectExtractProtectingDementia

Similar Articles

Cited By

No available data.